Prostate carcinoma risk subsequent to diagnosis of benign prostatic hyperplasia: A population-based cohort study in Sweden

Cancer

Volumn 98, Issue 8, 2003, Pages 1727-1734

  Chokkalingam, Anand P ^a   Nyrén, Olof ^b   Johansson, Jan Erik ^c   Gridley, Gloria ^a   McLaughlin, Joseph K ^d   Adami, Hans Olov ^b   Hsing, Ann W ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^d INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

Author keywords

Benign prostatic hyperplasia; Cohort; Epidemiology; Prostate carcinoma; Sweden; Transurethral resection; Transvesical adenomectomy

Indexed keywords

AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER REGISTRY; CANCER RISK; CANCER STATISTICS; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROSTATE SURGERY; RISK FACTOR; STATISTICAL SIGNIFICANCE; SWEDEN; TRANSURETHRAL RESECTION; TRANSVESICAL ADENOMECTOMY;

AGED; COHORT STUDIES; HUMANS; MALE; PROSTATECTOMY; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RISK FACTORS; SWEDEN; TRANSURETHRAL RESECTION OF PROSTATE;

EID: 0141958301     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11710     Document Type: Article

References (27)

1. Guess HA. Benign prostatic hyperplasia and prostate cancer. Epidemiol Rev. 2001;23:152-158.
2. Bostwick DG, Cooner WH, Denis L, Jones GW, Scardino PT, Murphy GP. The association of benign prostatic hyperplasia and cancer of the prostate. Cancer. 1992;70:291-301.
3. Hsing AW, Chua S Jr., Gao YT, et al. Prostate cancer risk and serum levels of insulin and leptin: a population-based study. J Natl Cancer Inst. 2001;93:783-789.
4. Hsing AW, Deng J, Sesterhenn IA, et al. Body size and prostate cancer: a population-based case-control study in China. Cancer Epidemiol Biomarkers Prev. 2000;9:1335-1341.
5. Andersson SO, Wolk A, Bergstrom R, et al. Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst. 1997;89:385-389.
6. Chokkalingam AP, Pollak M, Fillmore CM, et al. Insulin-like growth factors and prostate cancer: a population-based case-control study in China. Cancer Epidemiol Biomarkers Prev. 2001;10:421-427.
7. Signorello LB, Brismar K, Bergstrom R, et al. Insulin-like growth factor-binding protein-1 and prostate cancer. J Natl Cancer Inst. 1999;91:1965-1967.
8. Chokkalingam AP, Gao Y-T, Deng J, et al. Insulin-like growth factors and risk of benign prostatic hyperplasia. Prostate. 2002;52:98-105.
9. Dahle SE, Chokkalingam AP, Gao Y-T, Deng J, Stanczyk FZ, Hsing AW. Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia. J Urol. 2002;168:599-604.
10. Miller GJ, Torkko KC. Natural history of prostate cancer - epidemiologic considerations. Epidemiol Rev. 2001;23:14-18.
11. Greenwald P, Kirmss V, Polan AK, Dick VS. Cancer of the prostate among men with benign prostatic hyperplasia. J Natl Cancer Inst. 1974;53:335-340.
12. Armenian HK, Lilienfeld AM, Diamond EL, Bross ID. Relation between benign prostatic hyperplasia and cancer of the prostate. A prospective and retrospective study. Lancet. 1974;2:115-117.
13. Simons BD, Morrison AS, Young RH, Verhoek-Oftedahl W. The relation of surgery for prostatic hypertrophy to carcinoma of the prostate. Am J Epidemiol. 1993;138:294-300.
14. Nyren O, McLaughlin JK, Gridley G, et al. Cancer risk after hip replacement with metal implants: a population-based cohort study in Sweden. J Natl Cancer Inst. 1995;87:28-33.
15. Naessen T, Parker R, Persson I, Zack M, Adami HO. Time trends in incidence rates of first hip fracture in the Uppsala Health Care Region, Sweden, 1965-1983. Am J Epidemiol. 1989;130:289-299.
16. World Health Organization. International classification of diseases. 1965 revision. Vol. 1: Manual of the international statistical classification of diseases, injuries, and causes of death. Geneva: World Health Organization, 1967.
17. Nilsson AC, Spetz CL, Carsjo K, Nightingale R, Smedby B. [Reliability of the hospital registry. The diagnostic data are better than their reputation]. Lakartidningen. 1994;91:598-605.
18. Mattsson B, Wallgren A. Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol. 1984;23:305-313.
19. Mattsson B, Rutqvist LE, Wallgren A. Undernotification of diagnosed cancer cases to the Stockholm Cancer Registry. Int J Epidemiol. 1985;14:64-69.
20. The Swedish Cancer Registry. Cancer incidence in Sweden 1995. Stockholm: National Board of Health and Welfare, 1998.
21. Bailar JCI, Ederer F. Significance factors for the ratio of a Poisson variable to its expectation. Biometrics. 1964;20:639-643.
22. Chan JM, Giovannucci EL. Vegetables, fruits, associated micronutrients, and risk of prostate cancer. Epidemiol Rev. 2001;23:82-86.
23. Kolonel LN. Fat, meat, and prostate cancer. Epidemiol Rev. 2001;23:72-81.
24. Nomura AM. Body size and prostate cancer. Epidemiol Rev. 2001;23:126-131.
25. Lee IM, Sesso HD, Chen JJ, Paffenbarger RS Jr. Does physical activity play a role in the prevention of prostate cancer? Epidemiol Rev. 2001;23:132-137.
26. Blomqvist P, Ekbom A, Carlsson P, Ahlstrand C, Johansson JE. Benign prostatic hyperplasia in Sweden 1987 to 1994: changing patterns of treatment, changing patterns of costs. Urology. 1997;50:214-219.
27. Borth CS, Beiko DT, Nickel JC. Impact of medical therapy on transurethral resection of the prostate: a decade of change. Urology. 2001;57:1082-1085.